IWT Supports Agfa HealthCare Innovation with 3.5 Million Euro for IT R&D Centers

Agfa HealthCareAgfa HealthCare, a leading provider of diagnostic imaging and healthcare IT solutions, announces today that it has been awarded a 3.5 million Euro (4.7 million US$) grant by the Flemish Agency for Innovation by Science and Technology (IWT) for its IT research & development (R&D) program. The funds, which will be released over a period of three years, will support the R&D centers in Flanders for the next generation of integrated medical information and imaging systems.

Innovation key to improving healthcare and patient care
IWT awarded the grant based on the technological innovation power and strong potential for business valorization of Agfa HealthCare's R&D program. The program firmly establishes Agfa HealthCare's R&D facilities in Ghent and Mortsel alongside the company's other R&D centers in North America, Europe and China. Together, these centers will develop advanced technology for image-intensive clinical applications for radiology and cardiology, amongst others.

The program advances Agfa HealthCare's goal to continuously increase the efficiency of healthcare and improve the delivery of patient care, through innovation. "We strongly believe that innovation is an essential component for our future success, and the funds provided by the IWT will help us to realize our ambitious R&D program," explains Christian Reinaudo, CEO Agfa-Gevaert NV.

Agfa HealthCare diversifies financial sources for R&D
The grant comes soon after the European Investment Bank (EIB) signed a contract to lend Agfa HealthCare 130 million Euro (176 million US$) for R&D in the Ghent and Mortsel centers, as well as in the company's other European R&D facilities in Germany, Austria and France. This agreement, concluded in November 2010, will contribute - with the IWT grant - to the company's internal growth strategy as well as its efforts to further diversify its financing sources.

Related news articles:

About IWT
IWT, the Flemish Agency for Innovation by Science and Technology, helps Flemish companies, research centers and organizations realize their research and development projects, by providing financial funding, advice and a network of potential partners in Flanders and abroad. It works to promote close cooperation between all players in the domain of technical innovation in Flanders. IWT also supports the Flemish Government in establishing its innovation policy.

About Agfa
The Agfa-Gevaert Group is one of the world's leading companies in imaging and information technology. Agfa develops manufactures and markets analogue and digital systems for the printing industry (Agfa Graphics), for the healthcare sector (Agfa HealthCare), and for specific industrial applications (Agfa Materials). Agfa is headquartered in Mortsel, Belgium. The company is present in 40 countries and has agents in another 100 countries around the globe. The Agfa-Gevaert Group achieved a turnover of 2,755 million euro in 2009.

About Agfa HealthCare
Agfa HealthCare, a member of the Agfa-Gevaert Group, is a leading global provider of diagnostic imaging and healthcare IT solutions. The company has nearly a century of healthcare experience and has been a pioneer on the healthcare IT market since the early 1990's. Today Agfa HealthCare designs, develops and delivers state-of-the-art systems for capturing, managing and processing diagnostic images and clinical/administrative information for hospitals and healthcare facilities, as well as contrast media solutions to enable effective medical imaging results. The company has sales offices and agents in over 100 markets worldwide. Sales for Agfa HealthCare in 2009 were 1,178 million euro. For more information on Agfa HealthCare, please visit www.agfahealthcare.com.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...